Zynex, Inc. (ZYXI) Tops Q1 EPS by 2c, Revenues Beat; Affirms Q2 Revenue Guidance Above Consensus
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Wall St futures muted as oil gains curb risk appetite after S&P record close
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Zynex Announces 2019 First Quarter Earnings
April 30, 2019 4:06 PM EDTENGLEWOOD, Colo., April 30, 2019 /PRNewswire/ --Â Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, today reported financial results for its first quarter ended March 31, 2019.
First Quarter Financial Results Summary:For the first quarter, the Company reported net revenue of $9.2 million, a 34%... More
